The Democratic National Committee is launching a new website today to show the impact of President Donald Trump’s tariffs and ...

In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO ...

The sector-specific tariffs are putting pressure on businesses and foreign nations as they try to navigate Trump’s constantly ...

Novartis AG announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, ...

Australia is “urgently seeking more detail” on U.S. President Donald Trump’s threat to raise tariffs up to 200% on ...

Donald Trump again has threatened a tariff on imported drugs, but has given the drug makers a year or so "to get their act ...

Johnson & Johnson halved its expectations for costs this year related to new tariffs and raised its full-year sales and ...

Australia is evaluating the impact of potential US tariffs of 200% on pharmaceutical imports, Treasurer Jim Chalmers said, while reiterating that his nation’s subsidies for certain drugs are not up ...

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...

Irish-made medicines heading to the US face steep new duties, raising alarm among patients, producers and investors on both ...

Some GOP lawmakers and pro-trade lobbyists are quietly seeking to rein in the most extreme elements of the Trump ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.